1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Molecular Design International, Inc. - Product Pipeline Review - 2015

Molecular Design International, Inc. - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 22 pages

Molecular Design International, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Molecular Design International, Inc. - Product Pipeline Review - 2015’, provides an overview of the Molecular Design International, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Design International, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Molecular Design International, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Molecular Design International, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Molecular Design International, Inc.’s pipeline products

Reasons to buy

- Evaluate Molecular Design International, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Molecular Design International, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Molecular Design International, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Molecular Design International, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molecular Design International, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Molecular Design International, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Molecular Design International, Inc. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Molecular Design International, Inc. Snapshot 4
Molecular Design International, Inc. Overview 4
Key Information 4
Key Facts 4
Molecular Design International, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Molecular Design International, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Molecular Design International, Inc. - Pipeline Products Glance 9
Molecular Design International, Inc. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Molecular Design International, Inc. - Drug Profiles 10
MDI-301 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
Small Molecules For Cancer 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Small Molecules for Diabetes 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Small Molecules to Agonize Beta3 Adrenoceptors for Obesity 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Molecular Design International, Inc. - Pipeline Analysis 15
Molecular Design International, Inc. - Pipeline Products by Target 15
Molecular Design International, Inc. - Pipeline Products by Route of Administration 16
Molecular Design International, Inc. - Pipeline Products by Molecule Type 17
Molecular Design International, Inc. - Pipeline Products by Mechanism of Action 18
Molecular Design International, Inc. - Dormant Projects 19
Molecular Design International, Inc. - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 21
Disclaimer 22

List of Tables
Molecular Design International, Inc., Key Information 4
Molecular Design International, Inc., Key Facts 4
Molecular Design International, Inc. - Pipeline by Indication, 2015 6
Molecular Design International, Inc. - Pipeline by Stage of Development, 2015 7
Molecular Design International, Inc. - Monotherapy Products in Pipeline, 2015 8
Molecular Design International, Inc. - Preclinical, 2015 9
Molecular Design International, Inc. - Pipeline by Target, 2015 15
Molecular Design International, Inc. - Pipeline by Route of Administration, 2015 16
Molecular Design International, Inc. - Pipeline by Molecule Type, 2015 17
Molecular Design International, Inc. - Pipeline Products by Mechanism of Action, 2015 18
Molecular Design International, Inc. - Dormant Developmental Projects,2015 19

List of Figures
Molecular Design International, Inc. - Pipeline by Top 10 Indication, 2015 6
Molecular Design International, Inc. - Pipeline by Top 10 Target, 2015 15
Molecular Design International, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 18

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.